ArticleThe Journal of biological chemistry2017

Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

Victoria Stepanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.